Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Korsana Biosciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +2 vs. Q1 2024
- Shares held
- 1.05M
- −18.5K (−1.7%) vs. Q1 2024
- Total value
- $2.41M
- −$1.01M (−29.6%) vs. Q1 2024
- New holders
- 3
- 4 more added
- Sold out
- 1
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $11.2M |
| Q1 2026 | 17 | $249.0K |
| Q4 2025 | 19 | $376.3K |
| Q3 2025 | 17 | $595.4K |
| Q2 2025 | 17 | $1.06M |
| Q1 2025 | 18 | $931.7K |
| Q4 2024 | 19 | $1.23M |
| Q3 2024 | 15 | $2.70M |
| Q2 2024 | 17 | $2.41M |
| Q1 2024 | 15 | $3.42M |
| Q4 2023 | 15 | $3.58M |
| Q3 2023 | 17 | $3.66M |
| Q2 2023 | 18 | $4.10M |
| Q1 2023 | 34 | $8.95M |
| Q4 2022 | 40 | $13.7M |
| Q3 2022 | 38 | $18.3M |
| Q2 2022 | 41 | $11.5M |
| Q1 2022 | 50 | $25.6M |
| Q4 2021 | 56 | $40.7M |
| Q3 2021 | 62 | $75.8M |
| Q2 2021 | 68 | $96.0M |
| Q1 2021 | 71 | $62.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Korsana Biosciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 1 | $2 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 2 | $5 | 0.00% | +2 | New |
| Bank of America Corp | 16 | $37 | 0.00% | +16 | New |
| Activest Wealth Management | 100 | $230 | 0.00% | +100 | New |
| Royal Bank of Canada | 416 | $1.00K | 0.00% | +64+18.2% | Added |
| Group One Trading, L.P. | 540 | $1.23K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 649 | $1.49K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,464 | $3.37K | 0.00% | +1,431+4,336.4% | Added |
| UBS Group AG | 2,706 | $6.22K | 0.00% | +182+7.2% | Added |
| BlackRock Inc. | 17,169 | $39.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 23,490 | $54.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 33,978 | $77.5K | 0.00% | +1,896+5.9% | Added |
| Artal Group S.A. | 117,643 | $270.6K | 0.01% | −21,312−15.3% | Reduced |
| FMR LLC | 161,419 | $368.0K | 0.00% | −908−0.6% | Reduced |
| Tyndall Capital Partners L P | 164,777 | $379.0K | 100.00% | 00.0% | Unchanged |
| MFN Partners Management, LP | 169,460 | $386.4K | 0.01% | 00.0% | Unchanged |
| Slate Path Capital LP | 357,880 | $823.1K | 0.02% | 00.0% | Unchanged |
| Wells Fargo & Company | 0 | $0 | 0.00% | −15−100.0% | Sold out |